2-氨基-N-(2-苯基乙基)醋胺石盐酸 | 55677-60-6

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基-N-(2-苯基乙基)醋胺石盐酸
• 英文名称: α-amino-N-(2-phenylethyl)acetamide hydrochloride
• 英文别名: glycyl-2-phenylethylamine hydrochloride；2-amino-N-phenethylacetamide hydrochloride；[(2-phenylethyl)carbamoyl]methanaminium chloride；glycine phenethylamide; hydrochloride；Glycin-phenaethylamid; Hydrochlorid；2-amino-N-(2-phenylethyl)acetamide hydrochloride；2-amino-N-(2-phenylethyl)acetamide;hydrochloride
• CAS: 55677-60-6
• 化学式: C₁₀H₁₄N₂O*ClH
• mdl: MFCD14705831
• 分子量: 214.695
• InChiKey: IAGTYRDQZLLIDL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.28
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  55.1
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-氨基-N-(2-苯基乙基)醋胺石盐酸 在 palladium on activated charcoal N-甲基吗啉 、 盐酸 、 二氯乙酸 、 N-羟基-7-氮杂苯并三氮唑 、 氢气 、 1-羟基苯并三唑 、 二甲基亚砜 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 乙醇 、 水 、 溶剂黄146 、 乙酸乙酯 、 甲苯 、 乙腈 为溶剂， 反应 2.0h， 生成 (R)-5-Guanidino-2-phenylmethanesulfonylamino-pentanoic acid ({(S)-1-benzyl-2-oxo-2-[(phenethylcarbamoyl-methyl)-carbamoyl]-ethylcarbamoyl}-methyl)-methyl-amide
  参考文献：
  名称：

  Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic p1-ketoamide moieties

  摘要：

  Judicious combination of P-region sequences of highly potent anticoagulant proteins including NAPS, NAP6, Ecotin, and Antistasin with SAR from small molecule FXa inhibitors led to a series of chimeric inhibitors of formula 1a-j. We report herein the design, synthesis, and biological activity of this novel family of FXa inhibitors that express both high in vitro potency and superb selectivity against related serine proteases. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00458-3
• 作为产物：
  描述：

  tert-butyl (2-oxo-2-(phenethylamino)ethyl)carbamate 在 盐酸 、 水 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以98%的产率得到2-氨基-N-(2-苯基乙基)醋胺石盐酸
  参考文献：
  名称：

  不对称二硫烷基苯甲酰胺作为金黄色葡萄球菌分选酶 A 的不可逆选择性抑制剂。

  摘要：

  金黄色葡萄球菌是医院和社区获得性感染的最常见原因之一，耐药菌株每年导致数万人死亡。金黄色葡萄球菌分选酶 A 抑制剂旨在干扰毒力决定因素。我们已经确定二硫烷基苯甲酰胺是一类新型有效的分选酶 A 抑制剂，通过活性位点半胱氨酸的共价修饰发挥作用。合成了一系列广泛的衍生物来推导构效关系（SAR）。体外和计算机方法使实验观察到的结合亲和力和选择性合理化。研究发现，最活跃的化合物具有个位数的微摩尔 Ki 值，在 10 μM 的有效抑制剂浓度下，金黄色葡萄球菌纤维蛋白原附着量减少高达 66%。这种新分子类别表现出最小的细胞毒性、较低的细菌生长抑制和分选酶介导的金黄色葡萄球菌细胞粘附受损。

  DOI：

  10.1002/cmdc.201900687

文献信息

• Comparison of phosphonate transition state analogs for inducing catalytic antibodies and evaluation of key structural factors by an ab initio study
  作者：Hiroyuki Kakinuma、Kazuko Shimazaki、Naoko Takahashi、Kyoko Takahashi、Shigeo Niihata、Yoshiko Aoki、Katsumi Hamada、Hajime Matsushita、Yoshisuke Nishi

  DOI：10.1016/s0040-4020(99)00054-x

  日期：1999.2

  structure of haptens and the esterolytic activities of antibodies was investigated. We synthesized two phenylalanine analogs, the negatively charged phosphonate derivative 1 and the neutral phosphonamidate derivative 2. Seventeen out of 41 monoclonal antibodies generated against the hapten 1 hydrolyzed the relevant phenylalanine ester R-12. On the contrary, none of 27 monoclonal antibodies generated against

  研究了半抗原的结构与抗体的酯水解活性之间的关系。我们合成了两个苯丙氨酸类似物，带负电荷的膦酸酯衍生物1和中性的膦酰胺衍生物2。在针对半抗原1的41种单克隆抗体中，有17种水解了相关的苯丙氨酸酯R-12 。相反，针对半抗原2产生的27种单克隆抗体均没有催化活性。一个从头 对建模的半抗原的结构和电子性质的研究表明，膦酰基氧周围的负静电势值是影响酯水解抗体诱导的重要因素。
• Synthesis and evaluation of 1- and 2-substituted fentanyl analogs for opioid activity
  作者：Mohamed Y. H. Essawi、Philip S. Portoghese

  DOI：10.1021/jm00357a007

  日期：1983.3

  We synthesized fentanyl analogues that possess key groups common to the opioid peptides to investigate whether or not these two classes of compounds interact with common subsites on opioid receptors. The design of the analogues was based on the possibility of structural analogy between the two aromatic rings of fentanyl and the Tyr1 and Phe4 residues of the opioid peptides. The synthesized compounds showed very weak or no opioid activity as tested in the electrically stimulated longitudinal muscle of the guinea pig ileum or mouse vas deferens preparations. These results, together with those of reported studies, suggest that fentanyl and the opioid peptides interact with different subsites on either mu or sigma receptors. Studies using the irreversible mu opioid receptor antagonist, beta-funaltrexamine, indicate that fentanyl interacts preferentially with mu opioid receptors.
• Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma
  作者：Sang Min Lim、Yujeong Jeong、Suhyun Lee、Honggu Im、Hyun Seop Tae、Byung Gyu Kim、Hee Dong Park、Jonghoon Park、Sungwoo Hong

  DOI：10.1021/acs.jmedchem.5b01415

  日期：2015.11.12

  The treatment of activated B cell-like DLBCL (ABC-DLBCL) is one of the urgent unmet medical needs because it is the most resistant DLBCL subtype to current therapies eagerly awaiting effective therapeutic strategies. Recently, the paracaspase MALT1 has emerged as a promising therapeutic target for the treatment of ABC-DLBCL. Herein, we report a new class of MALT1 inhibitors developed by high-throughput screening and structure-based drug design. The original hit, 4-amino-1,2-naphthoquinone series inhibited MALT1 activity but suffered from poor cellular activity. The extensive pharmacophore search led to the discovery of structurally similar beta-lapachone that is a direct inhibitor of MALT1 and possesses favorable physicochemical properties. Molecular simulation studies suggested the possibility of the formation of a covalent bond between MALT1 and, beta-lapachone, which was corroborated by experimental wash-out studies. Inspired by this, we explored the structure activity relationships by incorporating electron-withdrawing substituents at C8 position of beta-lapachone. These MALT1 inhibitors exhibited potent antiproliferative activity to OCI-LY3 cell line and inhibited the cleavage of CYLD mediated MALT1.